The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...
from NDTV News - Special https://ift.tt/3jjsiDu
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment